Novavax CEO: Aim to have 1 to 2 million vaccine doses by 2021

Novavax CEO: Aim to have 1 to 2 million vaccine doses by 2021



Novavax President and CEO Stan Erck says his company has reached a ‘critical point’ in coronavirus vaccine development.